Tuesday, May 30, 2023
English News
  • Hyderabad
  • Telangana
  • Andhra Pradesh
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Reviews
    • Education Today
    • Property
    • Videos
    • Lifestyle
    • Rewind
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
  • Rewind
Home | Hyderabad | Hyderabad Drives Innovation For Covid Therapies

Hyderabad drives innovation for Covid therapies

The latest therapy with links to the city is the glucose molecule 2-DG and its anti-Covid-19 therapeutic application that was given a green signal by Indian drug regulatory authorities

By M. Sai Gopal
Published Date - 11:46 PM, Sun - 9 May 21
Hyderabad drives innovation for Covid therapies
Representational Image
whatsapp facebook twitter telegram

Hyderabad: Hyderabad continues to remain a preferred innovation hub for researchers and scientists involved in developing vaccines and anti-viral therapies for Covid-19. The latest therapy that has links to Hyderabad is the glucose molecule 2-deozy-D-glucose (2-DG) and its anti-Covid-19 therapeutic application that was given a green signal by the Indian drug regulatory authorities.

The anti-Covid-19 therapeutic application was developed by Delhi-based Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), in collaboration with city-based pharma giant Dr Reddy’s Laboratories and the Centre for Cellular and Molecular Biology (CCMB).

The INMAS has worked with Dr Reddy’s to develop the anti-Covid therapeutic application while at CCMB, the successful testing of the 2-deozy-D-glucose (2-DG) in coronavirus cell culture was take-up. “From testing of DRDO and Dr Reddy Lab’s 2-DG (2-deoxy-D-glucose) on coronavirus in cell culture at CCMB to successfully clearing the phase 3 trials, it will now be used on moderate to severe Covid-19 patients. DCGI approval has come,” the CCMB had tweeted on May 7.

Former Director and present advisor of CCMB Dr Rakesh Mishra said the anti-Covid-19 therapeutic application of 2-DG was the first drug tested in CCMB against the virus. The top geneticist congratulated the DRDO, Dr Reddy’s and the CCMB for bringing out such an innovative product.

According to INMAS, the clinical trial results of the molecule showed that it helps ‘in faster recovery of hospitalised patients and reduces supplemental oxygen dependence. Higher proportion of patients treated with 2-DG showed RT-PCR negative conversion in Covid patients’.

The Phase-III clinical trial was conducted on 220 patients between December 2020 to March 2021 at 27 Covid hospitals in Delhi, Uttar Pradesh, West Bengal, Gujarat, Rajasthan, Maharashtra, Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

Researchers familiar with the development said that Dr Reddy’s is expected to mass produce the molecule, which will be in the form of a powder. The drug will be prescribed as an adjunct or only as add-on to the already existing therapies.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


  • Follow Us :
  • Tags
  • CCMB
  • Centre for Cellular and Molecular Biology
  • Defence Research and Development Organisation
  • Dr Reddy’s Laboratories

Related News

  • DRDO assures all possible support to defence industries

    DRDO assures all possible support to defence industries

  • Editorial: Push for self-reliance

    Editorial: Push for self-reliance

  • Hyderabad geneticists establish new test for disease that caused amphibian apocalypse

    Hyderabad geneticists establish new test for disease that caused amphibian apocalypse

  • CCMB researchers develop non-invasive way to detect pig pheremone

    CCMB researchers develop non-invasive way to detect pig pheremone

  • ‘Western Ghats are both museum and cradle of diversity for woody plants’

    ‘Western Ghats are both museum and cradle of diversity for woody plants’

  • DRDO Centre of Excellence inaugurated at IIT-Hyderabad

    DRDO Centre of Excellence inaugurated at IIT-Hyderabad

Latest News

  • Johnny Depp cancels shows as doctor warns him not to fly after injury

    3 mins ago
  • New genes linked to heart attacks in women identified

    18 mins ago
  • Mahindra announces Thar 5-door launch date

    22 mins ago
  • Hyderabad: Jubilee Hills pub responds to criticism over exotic wildlife display

    35 mins ago
  • ChatGPT, electronic devices used to cheat in TSPSC exams

    43 mins ago
  • Biryani reigns supreme with 212 orders per minute this IPL season

    56 mins ago
  • AP govt. issues GO to CID to attach assets worth Rs 793 crore of Margadarsi Chit Fund

    1 hour ago
  • WhatsApp introduces ‘status archive’ feature for businesses on Android

    1 hour ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam